Results

Total Results: 5,570 records

Showing results for "disease".

21. Prevalence and Cost of Heart Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/cost-heart-disease.pdf
    May 21, 2021 - Prevalence and Cost of Heart Disease

22. Aspirin Use Evidence and Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/evidencenow/projects/heart-health/evidence/aspirin.html
    March 01, 2021 - Patients with heart disease or who have had a stroke in the past are at high risk for having a heart … For patients with heart disease, including those who have angina or have been treated for blocked arteries … panel recommended long-term, low-dose aspirin therapy (75 to 100 mg daily) for patients with heart disease … and the use of aspirin for primary and secondary prevention of heart disease. … Aspirin Algorithm This decision tree for aspirin treatment for heart disease prevention is for use by

23. Musculoskeletal Diseases | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/musculo.html
    June 01, 2018 - Chartbook on Effective Treatment Musculoskeletal Diseases Previous Page Next Page Table … Acknowledgments Effective Treatment Effective Treatment Trends and Measures Cardiovascular Disease … Diseases Respiratory Diseases National Healthcare Quality and Disparities Report … The Centers for Disease Control and Prevention predicts a 25% increase to 67 million U.S adults with … Centers for Disease Control and Prevention.

24. Healthcare Expenditures for Heart Disease Among Adults Aged 18 and Older | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/meps-statistical-brief550.html
    September 01, 2023 - Healthcare Expenditures for Heart Disease Among Adults Aged 18 and Older Medical Expenditure … Panel Survey Statistical Brief #550 In 2020, heart disease accounted for 20.6 percent of deaths in … Healthcare Expenditures for Heart Disease among Adults Aged 18 and Older in the U.S. … by select characteristics of the population, presents healthcare expenditures on heart disease by type … The percentage of adults who received any heart disease treatment was highest among those aged 65 and

25. Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment for Children With Sickle Cell Disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-scd-pain-specifications.pdf
    April 14, 2018 - Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment for Children With Sickle … Cell Disease 1 Sickle Cell Disease Measure 16: Appropriate Emergency Department Pain Assessment … for Children with Sickle Cell Disease Description The percentage of children identified as having … Hb F,S,C 282.63, 282.64 Hb SD-disease Hb F,S,D 282.68, 282.69 Hb SS-disease (sickle cell anemia) Hb … Hb F,C 282.7 Hb E-disease Hb F,E 282.7 Hb H-disease Hb F,H 282.49 Hb SE-disease Hb F,S,E 282.68,

26. Table A.4.1. Verisk condition classifications | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/taba.4.1.html
    December 01, 2017 - Fiscal year 2010 Liver Hepatic Coma Acute Liver Failure and Disease … Gallbladder Disorders Other Hepatitis and Liver Disease Substance Abuse Drug Induced … Other Diseases of Pulmonary Circulation Heart Infection/Inflammation, Except Rheumatic and Syphilitic … and Failure (All) Renal Failure:    Kidney Transplant    End Stage Renal Disease …   Hypertensive Heart Disease   Hypertensive Heart and Renal Disease or Encephalopathy

27. Respiratory Diseases | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/respiratory.html
    June 01, 2018 - Chartbook on Effective Treatment Respiratory Diseases Previous Page   Table of Contents … Acknowledgments Effective Treatment Effective Treatment Trends and Measures Cardiovascular Disease … Diseases Respiratory Diseases National Healthcare Quality and Disparities Report … Respiratory Disease Measures Process: Completion of tuberculosis therapy. … References Centers for Disease Control and Prevention.

28. Bringing the Patient Voice to Evidence Generation: Patient Engagement in Disease Registries | Agency for Healthcare Research and Quality
    www.ahrq.gov/news/blog/ahrqviews/disease-registries.html
    March 01, 2018 - from AHRQ leaders Bringing the Patient Voice to Evidence Generation: Patient Engagement in Disease … Disease registries currently comprise an important component of this knowledge ecosystem and are widely

29. Cardiovascular Disease | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/cvd.html
    June 01, 2018 - Chartbook on Effective Treatment Cardiovascular Disease Previous Page Next Page Table … Acknowledgments Effective Treatment Effective Treatment Trends and Measures Cardiovascular Disease … Diseases Respiratory Diseases National Healthcare Quality and Disparities Report … Measures of Effective Treatment of Cardiovascular Disease Treatment of Hypertension: Outcome … Cardiovascular Disease Measures for Which Disparities Were Eliminated Inpatient deaths per 1,000

30. Spanish Chronic Disease Self-Efficacy Scale (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/diabetesnetwork/spcdquest.pdf
    April 15, 2008 - Spanish Chronic Disease Self-Efficacy Scale … facilitador de servicios clínicos) Sexo: M o F Edad:______ Hispano: Sí o No Spanish Chronic Disease

31. Centers for Disease Control and Prevention (CDC) COVID-19 Vaccination | Agency for Healthcare Research and Quality
    www.ahrq.gov/nursing-home/resources/cdc-covid19-vaccination.html
    July 01, 2021 - Centers for Disease Control and Prevention (CDC) COVID-19 Vaccination Resource:   Centers for … Disease Control and Prevention (CDC) COVID-19 Vaccination This website includes information for COVID

32. Capacity for Chronic Disease Management in General Practice Research Study Practice Profile Interview—Linkages with External Organisations of Providers (GP-LI) 109 | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlasapd6.html
    March 01, 2013 - Clinical-Community Relationships Measures (CCRM) Atlas Capacity for Chronic Disease Management in General … Manual—Second Version Continuity of Care Practices Survey—Practice Level [CCPS-P] Capacity for Chronic Disease … Interview—Linkages with External Organisations of Providers (GP-LI) 109 Capacity for Chronic Disease

33. Health and economic outcomes of newborn screening for infantile-onset Pompe disease (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/priority-populations/richardson-et-al-2020.pdf
    January 01, 2020 - and treatment with ERT; and (2) NBS for Pompe disease and treatment of infantile-onset disease with … (atypical) Pompe disease without cardiomyopathy, and 60 have late-onset Pompe disease. … Other countries also cite additional considerations for treatments for rare diseases but have not put … may be cost-effective in the context of rare diseases. … The New York pilot newborn screening program for lyso- somal storage diseases: report of the first 65,000

34. Chronic Kidney Disease | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/nhqrdr/chartbooks/effectivetreatment/kidney.html
    June 01, 2018 - Diseases Respiratory Diseases National Healthcare Quality and Disparities Report … USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United … Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases … Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases … Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

35. Where to Find More Information | Agency for Healthcare Research and Quality
    www.ahrq.gov/questions/resources/diagnosis/information.html
    November 01, 2020 - Chronic Fatigue Syndrome Chronic Obstructive Pulmonary Disease Craniofacial and Skeletal Diseases … Heart Disease High Blood Pressure HIV/AIDS Immunodeficiency Disorders Infectious Diseases … Disorders Obesity Parkinson's Disease Rare Diseases and Disorders Skin Diseases Sleep Disorders … Groups Centers for Disease Prevention and Control http://www.cdc.gov/ncidod/diseases/cfs/support/ … Return to Specific Diseases and Conditions Chronic Obstructive Pulmonary Disease Organizations

36. Resources for Women’s Health | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/resources/womens-health.html
    July 01, 2018 - Resources for Women’s Health Research updates and information to help women manage diseases and … Cardiovascular disease. Ischemic heart disease. Heart failure. Hypertensive heart disease. … Inflammatory heart disease. … , stroke, complications of pregnancy, chronic obstructive pulmonary disease (COPD), and many other diseases … Knowing which screening tests are needed and when to get them, which medicines may prevent diseases,

37. Screening for Thyroid Disease: Systematic Evidence Review (pdf file)
    www.ahrq.gov/downloads/pub/prevent/pdfser/thyrser.pdf
    January 01, 2004 - TSH initially.40 The excess mortality was due primarily to higher mortality from cardiovascular diseases … signs of thyroid disease. … Introduction 20 disease. … In a MEDLINE® search, the medical subject headings (MeSH) thyroid function tests and thyroid diseases … or nodular thyroid disease.

38. Q-METRIC Sickle Cell Disease Measure 1 Section 1 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-132-scd-section-1.pdf
    October 01, 2013 - Q-METRIC Sickle Cell Disease Measure 1 Section 1     …   Q-METRIC Sickle Cell Disease Measure 1: Timeliness … of Confirmatory Testing for Sickle Cell Disease Graphics for Section I. … Hb F,S,C Hb SD-disease Hb F,S,D Hb SS-disease (sickle cell anemia) Hb F,S Hb SV-disease (unidentified … Hb F,E 282.7 Hb H-disease Hb F,H 282.49 Hb SE-disease Hb F,S,E 282.68, 282.69 Hb C-carrier Hb

39. Novel Role for Adiponectin-enhancing Drugs for Asthma in the Obese | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/chronic-care/decision/mcc/sood-grant.html
    September 01, 2015 - Period: 08/01/14--01/31/16 Grant Number : R01 HS023093-01 Description Asthma is a chronic lung disease … In addition, low adiponectin is similarly associated with depression and ischemic cardiovascular disease … Examine the role that anti-adiponectin drugs have on depression or ischemic cardiovascular disease. … Examine the effect of gender on the effect of anti-adiponectin drugs on above diseases. … in the obese Chronic Conditions Considered Asthma, depression, ischemic cardiovascular disease

40. Table 8: Prevalence of selected conditions among adults with diabetes by project site. Fiscal year 2010. | Agency for Healthcare Research and Quality
    www.ahrq.gov/practiceimprovement/delivery-initiative/ihs/chap5tab8.html
    December 01, 2017 - Project site  Hypertension Any cardiovascular diseases (CVD) Renal disease or failure Amputations … Mental health disorders Liver disease Percent Percent Percent Percent Percent Percent … All project sites 77.9% 31.6% 13.3% 2.4% 23.5% 6.8% CVD includes ischemic heart disease … , congestive heart failure (CHF) and other forms of heart disease, cerebrovascular disease and vascular … disease.